Purpose: The aim of our study was to analyze factors including survival, implantation and pregnancy rate, patients' age and BMI, abortions and extra uterine pregnancies that might influence the outcome of ICSI-ET thawing cycles.
Methods: A total of 147 cycles with embryos cryopreserved at different developmental stages were retrospectively evaluated.
Results: No difference was found in the survival, implantation and pregnancy rates of embryos cryopreserved on Day 2-3 and 5. However, in the pregnant group significantly higher implantation rate was observed with Day 5 blastocysts then with Day 2 or 3 early embryos. We found no difference in the number of abortions and extra uterine pregnancies between fresh and frozen ICSI-ET cycles. Higher BMI was found in the pregnant than in the nonpregnant group. However, the age of patient had no effect on the results.
Conclusions: Developmental stage of embryo and patients' BMI influences the success of ICSI-ET thawing cycles.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3455503 | PMC |
| http://dx.doi.org/10.1007/s10815-005-4920-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of efficacy of long follicular phase regimen and antagonist regimen on pregnancy outcome of fresh cycle or freeze-thawed cycle embryo transfer.
Pak J Med Sci
November 2024
Yuzhen Wang, Department of Reproductive Medicine, Baoding Maternal and Child Health Care Hospital, Baoding 071000, Hebei, China.
Article Synopsis
- The study aims to compare pregnancy outcomes between fresh and frozen embryo transfers in patients using two different treatment regimens: long follicular phase and antagonist regimens.
- A total of 543 patients' data were analyzed, revealing that pregnancy and implantation rates were significantly higher in certain groups compared to others, while factors like age and the number of retrieved oocytes influenced pregnancy rates.
- The antagonist regimen was found to be more effective, offering lower dosages and shorter medication times, thus enhancing embryo utilization and reducing costs for patients.
A repeated gonadotropin-releasing hormone agonist trigger improves pregnancy outcomes of frozen-thawed embryo transfer in GnRH antagonist cycles: a retrospective propensity-matched score analysis.
J Assist Reprod Genet
December 2024
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No 1838 Guangzhou Northern Road, Guangzhou, 510515, People's Republic of China.
Article Synopsis
- * In the analysis of 712 women, the results showed that the group receiving repeated GnRHa triggers had significantly higher IVF fertilization rates, good-quality embryo rates, clinical pregnancy rates (CPR), and live birth rates (LBR) compared to the single GnRHa group.
- * The findings suggest that using a repeated GnRHa trigger is more effective for achieving better reproductive outcomes in frozen embryo transfer (FET) cycles.
Chromosomal polymorphisms have no negative effect on reproductive outcomes after IVF/ICSI-ET/FET.
Sci Rep
November 2022
Reproductive Medicine Center, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha City, Hunan Province, People's Republic of China.
The present study aimed to explore whether chromosomal polymorphisms (CPs) have negative effects on reproductive outcomes of in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET)/frozen-thawing embryo transfer (FET)? We conducted a retrospective study consisting of 21,867 assisted reproductive technology treatment cycles, among which, fresh embryo transfer cycles accounted for 10,400, and the rest were FET cycles. According to karyotype of CPs, the former was grouped as: group 1 (male carrier, n = 425), group 2 (female carrier, n = 262), and group 3 (couple without CPs, n = 9713). Accordingly, FET cycles were divided into 3 groups: group 4 (male carrier, n = 298), group 5 (female carrier, n = 311), and group 6 (couple without CPs, n = 10,858).
View Article and Find Full Text PDFEffects of localisation of uterine adenomyosis on outcome of in vitro fertilisation/intracytoplasmic sperm injection fresh and frozen-thawed embryo transfer cycles: a multicentre retrospective cohort study.
Reprod Biol Endocrinol
June 2021
Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine, 010-8543, Akita, Japan.
Background: Uterine adenomyosis is a benign disease, common among women in their 40 and 50 s, characterised by ectopic endometrial tissue in the uterine myometrial layer. Adenomyosis causes infertility and has a negative effect on the outcomes of in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) embryo transfer (ET) cycles. It has also been reported to have different characteristics depending on the adenomyotic lesion localisation.
View Article and Find Full Text PDFComparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders.
BMC Pregnancy Childbirth
May 2021
Reproductive Center, Women and Children's Hospital of Hubei Province, No. 745, Wuluo Road, Hongshan District, 430070, Wuhan, China.
Background: The gonadotrophin-releasing hormone (GnRH) antagonist protocol has some advantages, such as a simple method, short medication duration, and low incidence of ovarian hyperstimulation syndrome, but whether the GnRH antagonist protocol is suitable for normal ovarian responders has been controversial. We compared the clinical outcomes of fresh and frozen-thawed transfer cycles between the depot GnRH agonist protocol and GnRH antagonist protocol in normal ovarian responders.
Methods: Data of normal ovarian responders who underwent in vitro fertilization-embryo transfer (IVF-ET) or intracytoplasmic sperm injection-embryo transfer (ICSI-ET) between January 2017 and December 2018 in our hospital were retrospectively analysed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!